Brazil In Vitro Fertilization (IVF) Market Size, Share and Opportunity Analysis 2026–2034

Brazil in vitro fertilization (IVF) market grew from USD 185.06 Million in 2025 to USD 204.14 Million in 2026. Looking forward, the market is expected to reach USD 447.47 Million by 2034, exhibiting a CAGR of 10.31% during 2026-2034.

Brazil In Vitro Fertilization (IVF) Market Report 2026

Market Size in 2025: USD 185.06 Million

Market Size in 2026: USD 204.14 Million

Market Forecast in 2034: USD 447.47 Million

Market Growth Rate: 10.31% (2026-2034)

According to a recent study by IMARC Group Research Report, titled “Brazil In Vitro Fertilization (IVF) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034,” the Brazil in vitro fertilization (IVF) market grew from USD 185.06 Million in 2025 to USD 204.14 Million in 2026. Looking forward, the market is expected to reach USD 447.47 Million by 2034, exhibiting a CAGR of 10.31% during 2026-2034.

Request a Free Sample PDF for Detailed Market Insights: https://www.imarcgroup.com/brazil-in-vitro-fertilization-market/requestsample

Brazil In Vitro Fertilization (IVF) Industry Trends and Demands in 2026:

Brazil’s IVF market is experiencing transformational growth in 2026, driven by shifting demographic patterns, declining natural fertility rates, and rapidly evolving societal attitudes toward assisted reproduction and family planning. The country’s reproductive medicine sector is projected to surpass BRL 3 billion in 2026, up from BRL 1.3 billion in 2023, reflecting the rapid mainstreaming of IVF and other assisted reproductive technologies among Brazilian couples and single individuals. Between 2020 and 2023, 284,232 embryos were frozen in Brazil according to ANVISA’s SisEmbrio report, with 67.2% concentrated in the Southeast region, underscoring the growing normalization of fertility preservation as part of family planning strategies across the country.

The integration of artificial intelligence into fertility diagnostics, embryo selection, and clinical workflow management is fundamentally elevating IVF success rates and patient care quality across Brazil’s expanding network of fertility clinics and hospitals. Rising demand for Frozen Non-donor and IVF with ICSI procedures is reshaping service mix across both private fertility clinics and hospital-based fertility programs, while the premium instrument segment — led by imaging systems, incubators, and cryosystems — continues to attract strong investment. Fertility clinics dominating with a 59% market share are investing in AI-assisted embryo evaluation tools, expanded cryopreservation capacity, and digital patient management platforms to meet growing service demand and improve competitive differentiation.

How AI is Reshaping the Future of the Brazil In Vitro Fertilization (IVF) Market:

  • AI-Powered Embryo Selection and Quality Assessment: Artificial intelligence is transforming IVF success rates across Brazil’s fertility clinics by enabling automated, highly accurate embryo quality assessment that significantly outperforms traditional manual evaluation methods. AI-driven imaging systems and time-lapse incubation platforms analyze thousands of developmental data points from each embryo to predict implantation potential with unprecedented precision, enabling embryologists to select the highest-quality embryos for transfer. This technology is improving clinical outcomes for Brazilian patients, reducing the number of treatment cycles required, and strengthening the competitive positioning of leading fertility clinics investing in AI-assisted embryology infrastructure.

  • AI-Driven Ovarian Stimulation Protocol Personalization: AI systems are enabling Brazil’s fertility specialists to develop highly individualized ovarian stimulation protocols that maximize egg retrieval outcomes while minimizing ovarian hyperstimulation syndrome (OHSS) risk for each patient. Machine learning models analyze patient hormonal profiles, ovarian reserve measurements, age, and historical treatment response data to recommend optimal drug dosages and stimulation timing adjustments in real time. This personalization capability is improving treatment efficiency, patient safety, and overall IVF success rates across Brazil’s fertility clinics, contributing to the growing adoption of AI-assisted reproductive endocrinology protocols.

  • AI-Enhanced Patient Journey Management and Predictive Analytics: AI-powered clinical management platforms are streamlining the end-to-end IVF patient journey in Brazil by automating appointment scheduling, treatment monitoring, laboratory workflow coordination, and outcome documentation. Predictive analytics tools analyze patient cohort data to identify factors associated with successful outcomes and optimize clinical decision-making across egg retrieval, fertilization, embryo culture, and transfer stages. These intelligent workflow systems are enabling Brazil’s fertility clinics to serve larger patient volumes, improve operational efficiency, and deliver more consistent clinical quality as demand for IVF services continues to accelerate across the country.

Brazil In Vitro Fertilization (IVF) Market Segmentation:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest Brazil in vitro fertilization (IVF) market share. It includes forecasts for the period 2026-2034 and historical data from 2020-2025 for the following segments.

Breakup by Product:

  • Reagent (Cryopreservation Media, Embryo Culture Media, Ovum Processing Media, Sperm Processing Media)

  • Instrument (Imaging Systems, Incubators, Cryosystems, IVF Cabinet, Ovum Aspiration Pump, Sperm Separation Systems, Micromanipulator Systems, Others)

  • Accessories

Breakup by Procedure Type:

  • Fresh Donor

  • Frozen Donor

  • Fresh Non-Donor

  • Frozen Non-Donor

Breakup by Cycle Type:

  • Conventional IVF

  • IVF with ICSI

  • IVF with Donor Eggs

Breakup by End User:

  • Fertility Clinics

  • Hospitals

  • Others

Regional Insights:

  • Southeast

  • South

  • Northeast

  • North

  • Central-West

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Brazil In Vitro Fertilization (IVF) industry.

  • Vitrolife AB

  • CooperSurgical Inc.

  • Merck KGaA

  • Thermo Fisher Scientific Inc.

  • Origio A/S (CooperSurgical)

Recent News and Developments in Brazil In Vitro Fertilization (IVF) Market:

July 2026: Global demand for IVF continues to accelerate, with the global market projected to reach USD 45.90 billion by 2031 at a compound annual growth rate from 2026 levels, driven by changing demographic patterns, rising infertility rates, and expanding access to reproductive healthcare — dynamics that are directly reinforcing Brazil’s rapidly growing IVF market as one of the most dynamic in Latin America.

Ongoing 2026: Brazil’s reproductive medicine market is projected to surpass BRL 3 billion in 2026, driven by increasing demand for frozen non-donor procedures and IVF with ICSI cycles. AI integration into embryo selection, time-lapse imaging, and patient management platforms continues to elevate clinical success rates across Brazil’s Southeast-dominant fertility clinic network, while growing awareness of fertility preservation options is broadening the demographic reach of IVF services nationwide.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302